These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4404534)

  • 1. [New test for determination of CPK activity].
    Ferracin GS
    Quad Sclavo Diagn; 1971 Mar; 7(1):462-8. PubMed ID: 4404534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability].
    Kanno M; Annaka S; Sato N; Shinoda M
    Iryo; 1968 Dec; 22(12):1364-71. PubMed ID: 5717702
    [No Abstract]   [Full Text] [Related]  

  • 3. [CPK (creatine phosphokinase)].
    Ishiura S; Sugita H
    Nihon Rinsho; 1979 Jun; Suppl():1868-70. PubMed ID: 491014
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study between CPK, LDH and their isoenzymes in the detection of carriers of Duchenne's type muscular dystrophy].
    Castro-Gago M; Rodríguez-Segade S; Paz M; Novo I; Pombo M; Tojo R
    An Esp Pediatr; 1985 Sep; 23(3):170-4. PubMed ID: 4073685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

  • 6. [Muscular dystrophies].
    Zellweger H; Ionasescu V; Conway TW
    Schweiz Med Wochenschr; 1972 Jun; 102(22):753-9. PubMed ID: 5035931
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on enzymatic activity in serum obtained from muscular dystrophic patients.
    Yamaji K; Imai H; Esaki K; Tokoro T; Hotta K
    Nagoya Med J; 1968 Apr; 14(1):55-64. PubMed ID: 5696330
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N; Haţegan D
    Rev Roum Neurol; 1973; 10(6):531-7. PubMed ID: 4771091
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some functional and biochemical characteristics of human lymphocytes in the normal state and in chronic lymphoid leukosis (review of the literature)].
    Luganova IS; Blinov MN
    Lab Delo; 1975; (2):67-71. PubMed ID: 46317
    [No Abstract]   [Full Text] [Related]  

  • 10. A temporal study of enzymes, isozymes, and histochemical changes in Duchenne's dystrophy and neurogenic atrophy.
    Hooshmand H
    Neurology; 1970 Apr; 20(4):409-10. PubMed ID: 5535061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-biochemical and genetic studies of myopathy].
    Davidenkova EF; Droznina TA; Markelov IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of the determination of cretaine phosphokinase activity (CPK) in certain diseases of the muscles.
    Hetnarska L
    Pol Med J; 1968; 7(3):742-6. PubMed ID: 5669716
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudohypertrophic muscular dystrophy of Cuchenne with manifestations in the heterozygote.
    Walker BA
    Birth Defects Orig Artic Ser; 1971 Feb; 7(2):108-9. PubMed ID: 5173116
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of exercise on serum enzymes.
    Fowler WM; Gardner GW; Kazerunian HH; Lauvstad WA
    Arch Phys Med Rehabil; 1968 Oct; 49(10):554-65. PubMed ID: 5685050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 17. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
    Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of creatine kinase activity using bioluminescence].
    Kühn HJ; Theml P; Pilz D
    Psychiatr Neurol Med Psychol (Leipz); 1984 Sep; 36(9):551-5. PubMed ID: 6514867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy.
    Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS
    Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.